Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
View ORCID ProfileKevin Zhang, Patricia Beckett, Salaheddin Abouanaser, Marek Smieja
doi: https://doi.org/10.1101/2020.12.04.20243766
Kevin Zhang
1Faculty of Medicine, University of Toronto, Toronto, Ontario, M5S 1A8, Canada
MD(c)Patricia Beckett
2St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, L8N 4A6, Canada
RNSalaheddin Abouanaser
2St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, L8N 4A6, Canada
MDMarek Smieja
2St. Joseph’s Healthcare Hamilton, Hamilton, Ontario, L8N 4A6, Canada
3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, L8S 4L8, Canada
MD, PhDArticle usage
Posted May 17, 2021.
Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection
Kevin Zhang, Patricia Beckett, Salaheddin Abouanaser, Marek Smieja
medRxiv 2020.12.04.20243766; doi: https://doi.org/10.1101/2020.12.04.20243766
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4365)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2814)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6721)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)